These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24726632)

  • 1. Quantifying the release of lactose from polymer matrix tablets with an amperometric biosensor utilizing cellobiose dehydrogenase.
    Knöös P; Schulz C; Piculell L; Ludwig R; Gorton L; Wahlgren M
    Int J Pharm; 2014 Jul; 468(1-2):121-32. PubMed ID: 24726632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.
    Khan GM; Jiabi Z
    J Control Release; 1998 Jul; 54(2):185-90. PubMed ID: 9724905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug.
    Khan GM; Zhu JB
    J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
    Efentakis M; Iliopoyloy A; Siamidi A
    Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
    Riis T; Bauer-Brandl A; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2007 Jan; 65(1):78-84. PubMed ID: 16919924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
    Park JS; Shim JY; Park JS; Choi YW; Jeong SH
    Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-generation biosensor for lactose based on newly discovered cellobiose dehydrogenase.
    Stoica L; Ludwig R; Haltrich D; Gorton L
    Anal Chem; 2006 Jan; 78(2):393-8. PubMed ID: 16408919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using NMR chemical shift imaging to monitor swelling and molecular transport in drug-loaded tablets of hydrophobically modified poly(acrylic acid): methodology and effects of polymer (in)solubility.
    Knöös P; Topgaard D; Wahlgren M; Ulvenlund S; Piculell L
    Langmuir; 2013 Nov; 29(45):13898-908. PubMed ID: 24106807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of binders on the release rates of direct molded verapamil tablets using twin-screw extruder in melt granulation.
    Tan DC; Chin WW; Tan EH; Hong S; Gu W; Gokhale R
    Int J Pharm; 2014 Mar; 463(1):89-97. PubMed ID: 24406670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers.
    Parojcić J; Durić Z; Jovanović M; Ibrić S
    Drug Deliv; 2004; 11(1):59-65. PubMed ID: 15168793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the drug release stability of different polymeric matrix tablets containing metronidazole.
    Szente V; Baska F; Zelkó R; Süvegh K
    J Pharm Biomed Anal; 2011 Mar; 54(4):730-4. PubMed ID: 21129883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.